Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial
J. Ast, A.R. Cieslewicz, K. Korzeniowska, P. Bogdanski*, E. Kazmierczak, J. Olszewski, A. Skoluda, A. Jablecka Department of Clinical Pharmacology, and *Department of Internal Medicine, Metabolic Disorders and Hypertension, Karol Marcinkowski University of Medical Sciences, Poznan (Poland)
Background and Objectives: It cannot be excluded that supplementation with L-arginine, by improving function of endothelium and hypotensive effect, can be advantegeous in prevention of cardiovascular diseases in healthy people. However, reports about hypotensive effect of L-arginine in healthy people are unclear. Moreover, no research including ambulatory blood pressure measurement (ABPM) has been conducted so far. Therefore, the aim of our study was to show if 4-week supplementation of healthy people with L-arginine influences blood pressure measured with ABPM.
Materials and Methods: The study was carried out on 19 healthy people randomized to 6 g/24-hour, 12 g/24-hours of L-arginine or placebo. ABPM was carried out 4 times: before randomization, after 2 and 4 weeks of supplementation and 2 weeks after finishing supplementation.
Results: It was found that 4 weeks of supplementation of healthy people with L-arginine (6 or 12 g/24-hour) led to nonsignificant decrease of systolic and diastolic blood pressure; the decrease was greater during night.
Conclusion: These findings showed that supplementation with L-arginine is not necessarily advantageous in healthy people.
Corresponding Author: Artur R. Cieslewicz, Ph.D.; e-mail: artcies@gmail.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J. Ast, A.R. Cieslewicz, K. Korzeniowska, P. Bogdanski*, E. Kazmierczak, J. Olszewski, A. Skoluda, A. Jablecka
Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial
Eur Rev Med Pharmacol Sci
Year: 2011
Vol. 15 - N. 12
Pages: 1375-1384